Bank Of New York Mellon Corp Nautilus Biotechnology, Inc. Transaction History

Bank Of New York Mellon Corp

  • $528 Trillion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$1.55 - $2.47 $208,411 - $332,113
134,459 New
134,459 $242,000
Q3 2022

Nov 14, 2022
BUY
$1.96 - $3.13 $24,901 - $39,766
12,705 Added 11.45%
123,683 $263,000
Q2 2022

Aug 15, 2022
BUY
$2.64 - $4.84 $239,928 - $439,868
90,882 Added 452.24%
110,978 $298,000
Q3 2021

Nov 12, 2021
BUY
$6.14 - $10.1 $123,389 - $202,969
20,096 New
20,096 $123,000

Others Institutions Holding NAUT

# of Institutions
82
Shares Held
63.9M
Call Options Held
2.9K
Put Options Held
500
View Full List

About Nautilus Biotechnology, Inc.

NAUT Quotes by TradingView
  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $324M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email